JMS Bartlett

Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients

Hager R. Ali, Elena Provenzano, Sarah‐Jane Dawson et al. · Annals of Oncology · 2014 · 790 citations · Full text

Medicine, Immunology, Oncology +14

Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial

Hager R. Ali, A. Dariush, Jeremy Thomas et al. · Annals of Oncology · 2017 · 51 citations · Full text

Medicine, Oncology, Pathology +17

Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trials

Helena Earl, Louise Hiller, Janet Dunn et al. · British Journal of Cancer · 2012 · 18 citations · Full text

Medicine, Oncology, Pharmacology +13

Abstract OT2-3-01: The LORIS trial: A multicentre, randomized phase III trial of standard surgery versus active monitoring in women with newly diagnosed low risk ductal carcinoma in situ

A. Francis, JMS Bartlett, SJ Bowden et al. · Cancer Research · 2013 · 17 citations

Medicine, Oncology, Surgery +10